Live Feeds

Source map — Novartis Pauses Autoimmune Cell Therapy Studies After Deaths

Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.

SourceTypeTrust
Fierce Biotech news 60%
BioPharma Dive news 60%
WSJ news 60%
FirstWord Pharma news 60%
Bloomberg.com news 60%
Reuters news 60%
Endpoints News news 60%
www.marketscreener.com news 50%
www.yahoo.com news 50%
www.pharmavoice.com news 50%
www.pharmexec.com news 50%
www.bioprocessintl.com news 50%
finance.yahoo.com news 50%
www.insidermonkey.com news 50%
www.thejakartapost.com news 50%
www.medicalbrief.co.za news 50%
www.biopharmadive.com news 50%
www.theweek.in news 50%
www.biospace.com news 50%